| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.5 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.04 | 0.5 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.5 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.5 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.5 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.5 |